BRAF(V600) mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study

por Cohn, Allen L, Day, Bann-Mo, Abhyankar, Sarang, McKenna, Edward, Riehl, Todd, Puzanov, Igor
Publicado 2017

A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update

por Makker, Vicky, Aghajanian, Carol, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., Messing, Mark, Dutta, Lea, Dutcus, Corina E., Huang, Jie, Schmidt, Emmett V., Orlowski, Robert, Taylor, Matthew H.
Publicado 2023

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

por Makker, Vicky, Taylor, Matthew H., Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., DiSimone, Christopher, Messing, Mark, Stepan, Daniel E., Dutcus, Corina E., Wu, Jane, Schmidt, Emmett V., Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
Publicado 2020